JO
PJP icon

John Overdeck’s Invesco Pharmaceuticals ETF PJP Stock Holding History

John Overdeck’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Sell
1,836
-22,664
-93% -$2.45M ﹤0.01% 4731
2026
Q1 		$2.54M Buy
+24,500
New +$2.59M ﹤0.01% 2581
2025
Q2 		– Sell
-4,800
Closed -$416K – 3452
2025
Q1 		$416K Buy
+4,800
New +$409K ﹤0.01% 2598

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

John Overdeck's PJP Position: Q2 2026 in Review

John Overdeck reduced its Invesco Pharmaceuticals ETF (PJP) stake by 93% in Q2 2026, selling an estimated $2.45M and leaving 1,836 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #4731.

John Overdeck first reported a position in PJP in Q1 2025 and has held it in 3 quarters since. The position peaked at $2.54M in Q1 2026. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • John Overdeck held 1,836 shares of Invesco Pharmaceuticals ETF worth $217K as of Q2 2026.
  • John Overdeck sold 22,664 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $2.45M.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4731 holding.
  • John Overdeck first reported a position in Invesco Pharmaceuticals ETF in Q1 2025 and has held it in 3 quarters since.
  • John Overdeck's Invesco Pharmaceuticals ETF position peaked at $2.54M in Q1 2026.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.